Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Total Liabilities Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual total liabilities in 2023 was 1.38 Billion CNY , down -8.08% from previous year.
Austar Lifesciences Limited's latest quarterly total liabilities in 2024 Q2 was 1.35 Billion CNY , down -1.97% from previous quarter.
Austar Lifesciences Limited reported annual total liabilities of 1.5 Billion CNY in 2022, up 19.81% from previous year.
Austar Lifesciences Limited reported annual total liabilities of 1.25 Billion CNY in 2021, up 47.07% from previous year.
Austar Lifesciences Limited reported quarterly total liabilities of 1.38 Billion CNY for 2023 Q4, down -7.27% from previous quarter.
Austar Lifesciences Limited reported quarterly total liabilities of 1.38 Billion CNY for 2023 FY, down -8.08% from previous quarter.

Annual Total Liabilities Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Total Liabilities of Austar Lifesciences Limited (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	1.38 Billion CNY	-8.08%
2022	1.5 Billion CNY	19.81%
2021	1.25 Billion CNY	47.07%
2020	854.27 Million CNY	27.18%
2019	671.69 Million CNY	14.15%
2018	588.44 Million CNY	46.68%
2017	401.18 Million CNY	8.82%
2016	368.66 Million CNY	-10.08%
2015	410 Million CNY	27.99%
2014	320.33 Million CNY	-33.05%
2013	478.47 Million CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	1.35 Billion CNY	-1.97%
2023 Q4	1.38 Billion CNY	-7.27%
2023 FY	1.38 Billion CNY	-8.08%
2023 Q2	1.49 Billion CNY	-0.88%
2022 Q4	1.5 Billion CNY	-1.72%
2022 Q2	1.53 Billion CNY	21.9%
2022 FY	1.5 Billion CNY	19.81%
2021 FY	1.25 Billion CNY	47.07%
2021 Q2	1.08 Billion CNY	26.6%
2021 Q4	1.25 Billion CNY	16.17%
2020 Q4	854.27 Million CNY	14.22%
2020 FY	854.27 Million CNY	27.18%
2020 Q2	747.91 Million CNY	11.35%
2019 Q4	671.69 Million CNY	7.71%
2019 FY	671.69 Million CNY	14.15%
2019 Q2	623.61 Million CNY	5.98%
2018 Q4	588.44 Million CNY	26.67%
2018 FY	588.44 Million CNY	46.68%
2018 Q2	464.55 Million CNY	15.8%
2017 Q4	401.18 Million CNY	16.4%
2017 FY	401.18 Million CNY	8.82%
2017 Q2	344.65 Million CNY	-6.51%
2016 Q2	377.49 Million CNY	-7.93%
2016 Q4	368.66 Million CNY	-2.34%
2016 FY	368.66 Million CNY	-10.08%
2015 Q4	410 Million CNY	22.27%
2015 Q2	335.33 Million CNY	4.68%
2015 FY	410 Million CNY	27.99%
2014 Q2	337.36 Million CNY	-27.64%
2014 FY	320.33 Million CNY	-33.05%
2014 Q4	320.33 Million CNY	-5.05%
2013 Q4	466.19 Million CNY	0.0%
2013 FY	478.47 Million CNY	0.0%

Peer Total Liabilities Comparison of Austar Lifesciences Limited

Name	Total Liabilities	Total Liabilities Difference
Vincent Medical Holdings Limited	243.51 Million HKD	-468.13%